Barbara Domayne Hayman
Membre du Comité d'Investissement chez Cambridge Enterprise Ltd.
Provenance du réseau au premier degré de Barbara Domayne Hayman
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.
40
| Subsidiary | Investment Managers | 40 |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Barbara Domayne Hayman via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer President Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ams Sensors UK Ltd.
 ams Sensors UK Ltd. Industrial MachineryProducer Manufacturing AMS Sensors UK Ltd. provides gas sensor solutions for consumer applications. The company was founded on June 20, 2007 and is headquartered in Cambridge, the United Kingdom. | Industrial Machinery | Founder Director/Board Member | |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
The Cambridge Angels
 The Cambridge Angels Investment ManagersFinance The Cambridge Angels (Cambridge Angels) is a venture capital firm founded in 1999 by Robert Sansom, David Cleevely and Doug Richard. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OXFORD BIODYNAMICS PLC | Biotechnology | Director/Board Member | |
Liver Group Charity
 Liver Group Charity Miscellaneous Commercial ServicesCommercial Services Liver Group Charity operates as a charity. The private company is based in London, UK. | Miscellaneous Commercial Services | Chairman | |
| WORLDWIDE HEALTHCARE TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
MTI Partners Ltd.
 MTI Partners Ltd. Investment ManagersFinance MTI Partners Ltd (MTI Partners) is an independent venture capital firm founded in 1983. The firm is headquartered in UK. | Investment Managers | Private Equity Investor | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fluidic Analytics Ltd.
 Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
| FRONTIER IP GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Pharmenable Ltd.
 Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Spirea Ltd.
 Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom. | Biotechnology | Director/Board Member | |
Qkine Ltd.
 Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member | |
DefiniGEN Ltd.
 DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Bayes Business School | College/University | Masters Business Admin | |
| Brunel University | College/University | Undergraduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Zihipp Ltd.
 Zihipp Ltd. Pharmaceuticals: MajorHealth Technology Zihipp Ltd. develops peptide hormones for the treatment of diabetes and obesity. | Pharmaceuticals: Major | Director/Board Member | |
Echion Technologies Ltd.
 Echion Technologies Ltd. Electrical ProductsProducer Manufacturing Echion Technologies Ltd. develops and manufactures battery materials. The firm offers Li-ion batteries, nano materials and automotive products. The company was founded by Jean de la Verpilliere, Alex Groombridge, Adam Boies and Michael de Volder in 2017 and is headquartered in Cambridge, the United Kingdom. | Electrical Products | Chairman | |
Cobra Biologics Holdings Ltd.
 Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Biotechnology | Director/Board Member | |
Power Integrations U.K. Ltd.
 Power Integrations U.K. Ltd. SemiconductorsElectronic Technology Power Integrations UK Ltd. provides energy-efficient power conversion products. Its applications include mobile, feature, smart phones and media tablets. The company was founded by Gehan Anil Joseph Amaratunga and is headquartered in Cambridge the United Kingdom. | Semiconductors | Founder |
Statistiques
Internationale
| Royaume-Uni | 48 |
| Etats-Unis | 3 |
| Danemark | 2 |
Sectorielle
| Health Technology | 26 |
| Commercial Services | 9 |
| Consumer Services | 7 |
| Finance | 4 |
| Producer Manufacturing | 3 |
Opérationnelle
| Director/Board Member | 186 |
| Corporate Officer/Principal | 71 |
| Private Equity Investor | 24 |
| Independent Dir/Board Member | 24 |
| Chairman | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Elaine Jones | 37 |
| Kate Bingham | 31 |
| John Berriman | 24 |
| Bobby G. Soni | 23 |
| David Holbrook | 23 |
| Ajay Chowdhury | 21 |
| Atul Pande | 20 |
| Anthony Charles Hickson | 18 |
| Pamela Garside | 12 |
| Christine Martin | 11 |
| Keith Blundy | 11 |
| John Halfpenny | 11 |
| Patrick Maxwell | 9 |
| Anne Dobree | 8 |
| Bradley Hardiman | 7 |
- Bourse
- Insiders
- Barbara Domayne Hayman
- Connexions Sociétés
